Index - P/E - EPS (ttm) -3.41 Insider Own 22.27% Shs Outstand 15.09M Perf Week -7.49%
Market Cap 313.27M Forward P/E - EPS next Y -4.32 Insider Trans 21.26% Shs Float 11.73M Perf Month -25.11%
Income -64.47M PEG - EPS next Q -1.23 Inst Own 43.31% Short Float 5.24% Perf Quarter 21.76%
Sales 0.00M P/S - EPS this Y 19.66% Inst Trans 5.01% Short Ratio 6.13 Perf Half Y 181.68%
Book/sh 7.03 P/B 2.95 EPS next Y 12.97% ROA -89.35% Short Interest 0.61M Perf Year 39.33%
Cash/sh 5.76 P/C 3.61 EPS next 5Y - ROE -112.67% 52W Range 4.00 - 31.01 Perf YTD 163.12%
Dividend Est. - P/FCF - EPS past 5Y - ROI -80.33% 52W High -33.05% Beta 2.22
Dividend TTM - Quick Ratio 7.19 Sales past 5Y 0.00% Gross Margin - 52W Low 419.00% ATR (14) 1.94
Dividend Ex-Date - Current Ratio 7.19 EPS Y/Y TTM 39.99% Oper. Margin 0.00% RSI (14) 38.55 Volatility 8.71% 8.65%
Employees 45 Debt/Eq 0.04 Sales Y/Y TTM - Profit Margin - Recom 1.12 Target Price 67.00
Option/Short Yes / Yes LT Debt/Eq 0.02 EPS Q/Q -316.56% Payout - Rel Volume 0.35 Prev Close 21.33
Sales Surprise - EPS Surprise 6.76% Sales Q/Q - Earnings Mar 04 BMO Avg Volume 100.31K Price 20.76
SMA20 -8.70% SMA50 -18.14% SMA200 49.78% Trades
Volume 35,093 Change -2.67%
Date
Action
Analyst
Rating Change
Price Target Change
May-06-24 Initiated H.C. Wainwright
Buy
$65
Apr-03-24 Initiated Evercore ISI
Outperform
$65
Mar-28-24 Initiated RBC Capital Mkts
Outperform
$70
Mar-18-24 Initiated TD Cowen
Outperform
Aug-11-23 Initiated CapitalOne
Overweight
$7
Feb-28-22 Initiated Cantor Fitzgerald
Overweight
$10
Nov-08-21 Initiated Credit Suisse
Outperform
$15
Oct-21-21 Initiated William Blair
Outperform
Oct-20-21 Initiated BMO Capital Markets
Outperform
$19
Oct-13-21 Initiated Oppenheimer
Outperform
$21
May-13-24 08:00AM
May-07-24 04:30PM
12:00PM
Apr-02-24 04:30PM
Mar-22-24 08:50AM
04:30PM
Loading…
Mar-21-24 04:30PM
Mar-19-24 08:00AM
Mar-15-24 08:00AM
Mar-14-24 12:00PM
Mar-06-24 12:53PM
08:50AM
Mar-04-24 07:30AM
Feb-26-24 04:30PM
Feb-23-24 08:00AM
Feb-19-24 08:50AM
08:00AM
Loading…
Feb-07-24 08:00AM
Feb-06-24 08:59AM
Feb-05-24 08:00AM
Feb-02-24 08:00AM
Jan-24-24 12:14PM
Jan-05-24 08:30AM
Jan-02-24 08:00AM
Dec-18-23 04:30PM
Dec-10-23 11:00AM
Nov-30-23 08:00AM
Nov-09-23 09:48AM
08:00AM
Nov-08-23 04:30PM
Nov-02-23 09:00AM
Nov-01-23 08:00AM
08:30AM
Loading…
Oct-09-23 08:30AM
08:00AM
Sep-25-23 08:00AM
Sep-21-23 08:00AM
Sep-15-23 08:00AM
Aug-11-23 04:05PM
Aug-04-23 04:51PM
Aug-02-23 08:00AM
Jun-22-23 08:00AM
Jun-20-23 08:00AM
Jun-13-23 08:00AM
May-12-23 04:05PM
May-10-23 08:00AM
Apr-13-23 08:00AM
Apr-10-23 04:05PM
Mar-31-23 08:00AM
Mar-23-23 08:00AM
Mar-09-23 08:00AM
Mar-08-23 04:05PM
Feb-17-23 08:20AM
08:10AM
08:00AM
Feb-16-23 04:05PM
Feb-03-23 04:05PM
Jan-30-23 08:00AM
Jan-27-23 01:10PM
Jan-25-23 08:00AM
Jan-24-23 04:25PM
Jan-13-23 08:00AM
Jan-10-23 08:00AM
Jan-04-23 08:00AM
Jan-03-23 08:00AM
Nov-10-22 04:05PM
Sep-26-22 08:00AM
Sep-23-22 08:00AM
Sep-15-22 08:00AM
Aug-12-22 04:05PM
Jun-23-22 04:05PM
Jun-20-22 10:59AM
Jun-07-22 08:00AM
Jun-06-22 08:00AM
May-27-22 08:00AM
(American City Business Journals)
May-17-22 08:00AM
May-12-22 04:05PM
Apr-28-22 08:00AM
Apr-26-22 04:05PM
Apr-22-22 08:00AM
Mar-31-22 08:00AM
Mar-25-22 07:30PM
Mar-21-22 08:30AM
Mar-18-22 04:05PM
Mar-10-22 08:00AM
Feb-28-22 08:00AM
Feb-24-22 05:19PM
Feb-02-22 01:38PM
Dec-08-21 11:15AM
08:30AM
Nov-20-21 08:21AM
Nov-12-21 04:05PM
Nov-09-21 08:00AM
Nov-08-21 08:00AM
Oct-15-21 09:39PM
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mahal Jeetinder Singh Chief Operating Officer Mar 12 '24 Option Exercise 7.10 900 6,390 25,909 Mar 12 09:33 PM Mahal Jeetinder Singh Chief Operating Officer Mar 12 '24 Sale 26.44 900 23,792 25,009 Mar 12 09:33 PM Velan Capital Investment Manag 10% Owner Feb 08 '24 Buy 12.95 350,000 4,532,500 1,188,500 Feb 09 08:40 PM Carlyle Group Inc. Former 10% Owner Feb 08 '24 Buy 12.95 190,000 2,460,500 1,066,189 Feb 12 06:23 PM WIGGANS THOMAS G Director Nov 28 '23 Buy 0.65 10,000 6,486 50,000 Nov 30 04:05 PM WIGGANS THOMAS G Director Nov 21 '23 Buy 0.64 10,000 6,383 40,000 Nov 22 04:06 PM WIGGANS THOMAS G Director Nov 20 '23 Buy 0.63 10,000 6,309 30,000 Nov 20 08:14 PM WIGGANS THOMAS G Director Nov 17 '23 Buy 0.60 10,000 5,966 20,000 Nov 20 08:14 PM WIGGANS THOMAS G Director Nov 16 '23 Buy 0.60 10,000 5,965 10,000 Nov 20 08:14 PM Lis William Director Oct 13 '23 Sale 0.85 7,965 6,777 53,521 Oct 13 06:56 PM Mahal Jeetinder Singh See Remarks Jun 13 '23 Option Exercise 0.71 9,000 6,390 296,223 Jun 13 08:54 PM Mahal Jeetinder Singh See Remarks Jun 13 '23 Sale 1.66 9,000 14,915 287,223 Jun 13 08:54 PM
Index - P/E - EPS (ttm) -26.69 Insider Own 0.55% Shs Outstand 66.90M Perf Week -4.98%
Market Cap 7.96B Forward P/E 17.02 EPS next Y 6.98 Insider Trans -14.63% Shs Float 66.68M Perf Month -3.26%
Income -1783.00M PEG - EPS next Q 1.01 Inst Own 102.80% Short Float 3.42% Perf Quarter -1.38%
Sales 3.70B P/S 2.15 EPS this Y 7.53% Inst Trans 9.13% Short Ratio 3.72 Perf Half Y 75.37%
Book/sh 36.13 P/B 3.29 EPS next Y 46.44% ROA -17.57% Short Interest 2.28M Perf Year 44.68%
Cash/sh 12.62 P/C 9.41 EPS next 5Y -9.00% ROE -51.87% 52W Range 63.44 - 135.51 Perf YTD 15.40%
Dividend Est. 0.88 (0.74%) P/FCF 31.84 EPS past 5Y - ROI -24.34% 52W High -12.40% Beta 1.65
Dividend TTM 0.88 (0.74%) Quick Ratio 2.34 Sales past 5Y 12.63% Gross Margin 39.02% 52W Low 87.12% ATR (14) 5.03
Dividend Ex-Date May 24, 2024 Current Ratio 3.69 EPS Y/Y TTM -1121.34% Oper. Margin 13.18% RSI (14) 46.61 Volatility 3.46% 3.86%
Employees 10200 Debt/Eq 2.05 Sales Y/Y TTM 2.72% Profit Margin -48.24% Recom 1.71 Target Price 143.33
Option/Short Yes / Yes LT Debt/Eq 2.02 EPS Q/Q 135.35% Payout - Rel Volume 4.37 Prev Close 130.50
Sales Surprise 2.24% EPS Surprise 57.69% Sales Q/Q 9.32% Earnings May 08 AMC Avg Volume 612.73K Price 118.71
SMA20 -0.08% SMA50 -4.10% SMA200 17.47% Trades
Volume 2,680,148 Change -9.03%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-01-23 Upgrade The Benchmark Company
Hold → Buy
$125
Dec-20-22 Upgrade KeyBanc Capital Markets
Sector Weight → Overweight
$100
Nov-04-22 Downgrade The Benchmark Company
Buy → Hold
Feb-23-22 Initiated Loop Capital
Buy
$200
Jan-26-22 Initiated KeyBanc Capital Markets
Sector Weight
Dec-27-21 Reiterated Needham
Buy
$215
Dec-13-21 Upgrade Citigroup
Neutral → Buy
$190
Oct-29-21 Resumed Rosenblatt
Buy
Aug-20-21 Resumed Citigroup
Neutral
$160
Jul-06-21 Resumed Deutsche Bank
Buy
$225
Dec-11-20 Reiterated Cowen
Outperform
$150 → $178
Sep-11-20 Initiated Berenberg
Buy
Jul-28-20 Reiterated Needham
Buy
$125 → $135
Jul-22-20 Initiated Rosenblatt
Buy
$162
Jun-25-20 Initiated Wells Fargo
Equal Weight
$120
Jun-18-20 Upgrade DA Davidson
Neutral → Buy
$150
Jun-15-20 Reiterated Needham
Buy
$125
Jun-15-20 Initiated Needham
Buy
$125
Apr-02-20 Downgrade DA Davidson
Buy → Neutral
$85
Mar-23-20 Downgrade Citigroup
Buy → Neutral
$130 → $85
Show Previous Ratings
May-13-24 11:01PM
02:25PM
09:49AM
06:37AM
May-10-24 12:30PM
10:35AM
Loading…
10:35AM
May-09-24 10:40PM
(Thomson Reuters StreetEvents)
10:59AM
May-08-24 06:15PM
05:32PM
05:14PM
(Associated Press Finance)
04:30PM
09:00AM
May-06-24 09:00AM
May-04-24 07:38AM
08:00AM
Loading…
Apr-15-24 08:00AM
Mar-08-24 11:30AM
Mar-04-24 01:00PM
Feb-29-24 01:57AM
Feb-28-24 04:00PM
Feb-26-24 01:00PM
Feb-09-24 09:01AM
Feb-08-24 09:57PM
(Thomson Reuters StreetEvents) +5.62%
10:30AM
Feb-07-24 05:12PM
(Associated Press Finance)
04:57PM
04:30PM
Feb-06-24 09:00AM
Jan-30-24 09:00AM
Jan-25-24 09:00AM
04:30PM
Loading…
Jan-24-24 04:30PM
Jan-23-24 08:00AM
Jan-22-24 04:10PM
Jan-08-24 09:00AM
Dec-20-23 09:00AM
Dec-07-23 09:00AM
Dec-04-23 07:00AM
Dec-01-23 11:31AM
05:40AM
Nov-23-23 05:08AM
Nov-07-23 09:00AM
Nov-03-23 03:32PM
Nov-01-23 06:17PM
(Associated Press Finance)
04:30PM
Oct-20-23 09:00AM
Oct-18-23 05:49AM
Oct-10-23 09:00AM
Oct-06-23 12:00PM
Oct-03-23 04:30PM
Sep-28-23 09:00AM
Sep-08-23 08:58AM
Sep-07-23 12:18PM
Sep-01-23 11:31AM
Aug-28-23 09:00AM
Aug-13-23 09:14AM
Aug-08-23 09:00AM
Aug-03-23 10:26PM
(Thomson Reuters StreetEvents)
11:26AM
Aug-02-23 07:35PM
06:32PM
04:30PM
Jul-21-23 09:00AM
Jul-18-23 09:00AM
Jul-13-23 02:56PM
Jun-21-23 08:00PM
Jun-11-23 09:29AM
Jun-01-23 08:10PM
04:39PM
May-21-23 08:24AM
May-20-23 08:23AM
May-18-23 08:19AM
May-17-23 09:00AM
May-04-23 02:03PM
May-03-23 08:45PM
07:41PM
04:30PM
Apr-27-23 12:10PM
Apr-26-23 08:00PM
10:02AM
Apr-17-23 09:00AM
Mar-31-23 10:49AM
Mar-29-23 11:30AM
Mar-12-23 11:45PM
Mar-05-23 09:41AM
Mar-01-23 03:48PM
09:05AM
Feb-28-23 10:53PM
(Thomson Reuters StreetEvents) +5.15%
10:45AM
10:45AM
Feb-27-23 06:45PM
04:30PM
Feb-22-23 08:46PM
Feb-19-23 07:10AM
Feb-16-23 05:52PM
Feb-13-23 08:14AM
08:00AM
Feb-11-23 07:19AM
Feb-10-23 06:00PM
Feb-07-23 09:00AM
Feb-06-23 10:30AM
MKS Instruments, Inc. provides instruments, systems, subsystems and process control solutions to measure, control, power, monitor, and analyze parameters of manufacturing processes to improve process performance and productivity for its customers. It operates through the following segments: Vacuum & Analysis, Light & Motion and Equipment & Solutions. The Vacuum & Analysis segment comprises pressure measurement and control, flow measurement and control, gas and vapor delivery, gas composition analysis, residual gas analysis, leak detection, control technology, ozone generation and delivery, RF & DC power, reactive gas generation and vacuum technology components. The Light & Motion segment includes lasers, photonics, sub-micron positioning, vibration control, and optics instruments. The Equipment & Solutions segment provides laser-based manufacturing systems solutions for the micro-machining industry that enable customers to optimize production. The company was founded in 1961 and is headquartered in Andover, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mora Elizabeth Director Apr 01 '24 Sale 133.00 250 33,250 16,862 Apr 02 11:36 AM Burke Kathleen Flaherty EVP, GC & Secretary Mar 01 '24 Sale 122.89 7,411 910,738 42,999 Mar 04 11:39 AM Moloney Jacqueline F Director Mar 01 '24 Sale 122.89 250 30,722 9,161 Mar 04 11:43 AM BAGSHAW SETH H EVP, CFO & Treasurer Feb 22 '24 Sale 123.28 32,865 4,051,629 1 Feb 26 11:51 AM Moloney Jacqueline F Director Feb 16 '24 Sale 124.10 1,917 237,933 9,411 Feb 20 03:21 PM COLELLA GERARD G Director Feb 09 '24 Sale 120.00 10,000 1,200,003 68,017 Feb 12 12:21 PM COLELLA GERARD G Director Jan 22 '24 Sale 110.00 10,000 1,100,004 78,017 Jan 23 01:45 PM Mora Elizabeth Director Jan 02 '24 Sale 100.90 250 25,225 17,112 Jan 03 01:54 PM Moloney Jacqueline F Director Dec 01 '23 Sale 82.23 250 20,558 11,328 Dec 04 10:17 AM Henry David Philip EVP, Operations & Corp Mktg Nov 07 '23 Buy 68.34 2,500 170,862 11,073 Nov 08 11:40 AM Mora Elizabeth Director Oct 02 '23 Sale 87.15 250 21,788 17,362 Oct 03 02:34 PM BAGSHAW SETH H EVP, CFO & Treasurer Sep 06 '23 Sale 97.30 25,000 2,432,584 20,547 Sep 07 01:03 PM COLELLA GERARD G Director Aug 31 '23 Sale 100.01 10,000 1,000,056 88,017 Sep 01 10:13 AM Moloney Jacqueline F Director Aug 28 '23 Sale 95.25 250 23,814 11,578 Aug 29 12:22 PM Burke Kathleen Flaherty EVP, GC & Secretary Aug 07 '23 Sale 101.23 11,563 1,170,543 42,738 Aug 08 12:21 PM Mora Elizabeth Director Jul 03 '23 Sale 108.49 250 27,122 17,612 Jul 05 12:30 PM Moloney Jacqueline F Director Jun 01 '23 Sale 97.16 225 21,861 11,828 Jun 02 11:46 AM Mora Elizabeth Director Jun 01 '23 Sale 97.16 200 19,432 17,862 Jun 02 11:50 AM
Index RUT P/E - EPS (ttm) -2.04 Insider Own 23.77% Shs Outstand 44.45M Perf Week -10.52%
Market Cap 2.19B Forward P/E - EPS next Y -2.41 Insider Trans -12.64% Shs Float 40.94M Perf Month -15.05%
Income -94.30M PEG - EPS next Q -0.56 Inst Own 67.74% Short Float 16.62% Perf Quarter -9.22%
Sales 0.00M P/S - EPS this Y -0.38% Inst Trans 1.76% Short Ratio 6.56 Perf Half Y 254.04%
Book/sh 6.49 P/B 6.28 EPS next Y -6.74% ROA -29.99% Short Interest 6.80M Perf Year 439.74%
Cash/sh 7.52 P/C 5.42 EPS next 5Y - ROE -36.89% 52W Range 7.10 - 50.78 Perf YTD 164.95%
Dividend Est. - P/FCF - EPS past 5Y 10.22% ROI -23.31% 52W High -19.75% Beta 1.09
Dividend TTM - Quick Ratio 28.05 Sales past 5Y 0.00% Gross Margin - 52W Low 473.94% ATR (14) 3.10
Dividend Ex-Date - Current Ratio 28.05 EPS Y/Y TTM 40.28% Oper. Margin 0.00% RSI (14) 46.54 Volatility 8.05% 7.23%
Employees 51 Debt/Eq 0.15 Sales Y/Y TTM - Profit Margin - Recom 1.40 Target Price 60.22
Option/Short Yes / Yes LT Debt/Eq 0.14 EPS Q/Q 30.25% Payout - Rel Volume 0.60 Prev Close 41.32
Sales Surprise - EPS Surprise -5.58% Sales Q/Q - Earnings May 09 BMO Avg Volume 1.04M Price 40.75
SMA20 -2.14% SMA50 -4.02% SMA200 62.30% Trades
Volume 617,844 Change -1.38%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-25-24 Initiated Oppenheimer
Outperform
$26
Jan-08-24 Initiated Cantor Fitzgerald
Overweight
Dec-18-23 Initiated Raymond James
Outperform
$29
Nov-10-23 Upgrade Jefferies
Hold → Buy
$18 → $26
Aug-16-23 Initiated Guggenheim
Buy
$27
Jan-04-23 Downgrade Wedbush
Outperform → Neutral
$33 → $8
Jan-04-23 Downgrade Jefferies
Buy → Hold
$32 → $6
Jul-12-22 Initiated JP Morgan
Overweight
$35
May-02-22 Initiated H.C. Wainwright
Buy
$35
Apr-19-22 Initiated Wedbush
Outperform
$32
May-10-24 05:38AM
May-09-24 01:53PM
08:00AM
May-07-24 04:38PM
Apr-23-24 05:09PM
(The Wall Street Journal)
05:29AM
Loading…
Apr-13-24 05:29AM
Apr-12-24 07:01PM
Apr-11-24 04:29PM
(Yahoo Finance Video) +17.30%
Apr-05-24 06:30PM
Apr-02-24 08:00AM
Mar-20-24 12:52PM
07:30AM
Feb-28-24 04:20PM
Feb-02-24 12:40PM
08:00AM
04:05PM
Loading…
Feb-01-24 04:05PM
Jan-29-24 11:50PM
06:15AM
Jan-25-24 06:30AM
Jan-12-24 06:44PM
Jan-08-24 08:01AM
08:00AM
Dec-27-23 08:00AM
Dec-15-23 10:15AM
Nov-14-23 05:05PM
09:55AM
Nov-09-23 09:29AM
08:00AM
Nov-04-23 10:00AM
Oct-30-23 08:00AM
09:35AM
Loading…
Oct-18-23 09:35AM
Oct-17-23 09:35AM
Oct-16-23 09:35AM
Oct-13-23 10:22AM
Sep-26-23 04:02PM
Aug-31-23 08:00AM
Aug-16-23 10:00AM
Aug-15-23 04:03PM
Aug-10-23 08:00AM
Aug-04-23 06:30PM
Jul-24-23 09:01AM
Jul-07-23 06:35PM
Jun-27-23 08:05AM
Jun-20-23 07:04PM
09:33AM
Jun-17-23 10:10AM
Jun-15-23 04:44PM
Jun-12-23 12:05PM
Jun-11-23 01:08PM
Jun-08-23 08:00AM
Jun-07-23 08:00AM
May-11-23 08:36AM
07:30AM
May-04-23 08:00AM
Mar-28-23 07:30AM
Feb-27-23 04:05PM
Feb-14-23 07:48AM
Feb-09-23 06:51AM
05:54AM
Feb-06-23 04:05PM
Feb-01-23 09:52PM
04:01PM
Jan-30-23 07:35AM
06:00AM
Jan-25-23 08:00AM
Jan-22-23 07:39AM
Jan-06-23 05:02AM
Jan-04-23 04:07PM
(Investor's Business Daily) -64.70%
12:20PM
10:22AM
06:52AM
Jan-03-23 04:01PM
Dec-20-22 04:05PM
Nov-25-22 07:38AM
Nov-22-22 07:30AM
Nov-17-22 07:30AM
Nov-09-22 07:30AM
Nov-05-22 04:50PM
Oct-17-22 07:30AM
Sep-15-22 09:55AM
Sep-07-22 07:30AM
Aug-29-22 09:55AM
Aug-12-22 09:55AM
Aug-10-22 07:30AM
Aug-04-22 07:30AM
Jul-06-22 07:30AM
Jun-18-22 08:20AM
Jun-04-22 02:30PM
Jun-02-22 07:30AM
May-20-22 04:05PM
May-16-22 07:30AM
May-05-22 04:05PM
May-03-22 04:33PM
May-02-22 07:06PM
Apr-12-22 07:30AM
Mar-24-22 06:30AM
Mar-21-22 07:30AM
Mar-17-22 07:30AM
Mar-01-22 07:30AM
Feb-22-22 05:29AM
Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR Apr 10 '24 Sale 40.00 5,714 228,560 53,171 Apr 12 04:02 PM Grant Sean CHIEF FINANCIAL OFFICER Apr 03 '24 Option Exercise 14.87 99,828 1,484,442 166,165 Apr 05 09:32 PM Grant Sean CHIEF FINANCIAL OFFICER Apr 03 '24 Sale 39.61 99,828 3,954,516 66,337 Apr 05 09:32 PM Grant Sean CHIEF FINANCIAL OFFICER Apr 03 '24 Sale 39.42 18,649 735,205 0 Apr 05 09:32 PM Katabi Maha Director Mar 25 '24 Sale 40.50 340,000 13,770,000 2,793,987 Mar 25 09:46 PM Katabi Maha Director Mar 22 '24 Sale 40.51 413,450 16,748,860 3,133,987 Mar 25 09:46 PM Katabi Maha Director Mar 21 '24 Sale 44.20 81,009 3,580,723 3,547,437 Mar 25 09:46 PM Katabi Maha Director Jan 30 '24 Buy 31.00 161,290 4,999,990 3,628,446 Feb 01 05:58 PM COMMODORE CAPITAL LP 10% Owner Jan 10 '24 Sale 18.00 1,050,000 18,900,000 4,400,000 Jan 12 09:55 PM Fordyce Marshall President and CEO Dec 29 '23 Option Exercise 2.87 13,516 38,854 256,877 Jan 03 04:15 PM Fordyce Marshall President and CEO Aug 21 '23 Sale 16.66 5,210 86,779 243,361 Aug 23 05:56 PM Curley Joanne Chief Development Officer Aug 21 '23 Sale 16.66 1,490 24,817 26,962 Aug 23 05:57 PM Lin Celia Chief Medical Officer Aug 21 '23 Sale 16.65 1,490 24,816 11,010 Aug 23 05:59 PM Young Joseph R SVP, Finance, Chief Acct Offcr Jul 05 '23 Option Exercise 3.94 10,000 39,396 32,679 Jul 06 04:05 PM Grant Sean Chief Financial Officer Jun 23 '23 Buy 16.60 5,000 83,000 5,992 Jun 23 04:05 PM COMMODORE CAPITAL LP 10% Owner Jun 20 '23 Buy 15.17 448,217 6,799,004 5,450,000 Jun 22 04:10 PM
Index - P/E 65.99 EPS (ttm) 0.20 Insider Own 22.14% Shs Outstand 384.83M Perf Week -22.02%
Market Cap 4.85B Forward P/E 12.01 EPS next Y 1.08 Insider Trans -0.01% Shs Float 291.13M Perf Month -18.13%
Income 77.90M PEG 6.19 EPS next Q 0.24 Inst Own 75.20% Short Float 4.37% Perf Quarter -19.10%
Sales 1.25B P/S 3.88 EPS this Y 0.22% Inst Trans -3.85% Short Ratio 2.02 Perf Half Y 2.94%
Book/sh 5.33 P/B 2.43 EPS next Y 6.65% ROA 1.12% Short Interest 12.72M Perf Year -38.84%
Cash/sh 1.18 P/C 11.01 EPS next 5Y 10.65% ROE 3.60% 52W Range 11.67 - 30.16 Perf YTD -29.91%
Dividend Est. - P/FCF 11.92 EPS past 5Y - ROI 2.33% 52W High -57.02% Beta 1.09
Dividend TTM - Quick Ratio 1.11 Sales past 5Y 56.47% Gross Margin 84.18% 52W Low 11.05% ATR (14) 0.78
Dividend Ex-Date - Current Ratio 1.11 EPS Y/Y TTM -21.95% Oper. Margin 19.75% RSI (14) 33.99 Volatility 5.62% 3.84%
Employees 3516 Debt/Eq 0.68 Sales Y/Y TTM 7.93% Profit Margin 6.24% Recom 2.33 Target Price 17.67
Option/Short Yes / Yes LT Debt/Eq 0.67 EPS Q/Q -63.85% Payout 0.00% Rel Volume 1.54 Prev Close 12.76
Sales Surprise 0.43% EPS Surprise 10.92% Sales Q/Q 3.13% Earnings May 07 AMC Avg Volume 6.30M Price 12.96
SMA20 -15.91% SMA50 -17.81% SMA200 -20.98% Trades
Volume 9,719,895 Change 1.57%
Date
Action
Analyst
Rating Change
Price Target Change
May-08-24 Downgrade Piper Sandler
Overweight → Neutral
$24 → $15
May-08-24 Downgrade Mizuho
Buy → Neutral
$23 → $14
May-08-24 Downgrade Goldman
Neutral → Sell
$19.50 → $12
Mar-21-24 Initiated KeyBanc Capital Markets
Overweight
$20
Feb-08-24 Downgrade Citigroup
Neutral → Sell
$20 → $13
Feb-07-24 Initiated Jefferies
Buy
$20
Feb-01-24 Downgrade Morgan Stanley
Overweight → Equal-Weight
$24 → $20
Jan-29-24 Upgrade BofA Securities
Neutral → Buy
$20 → $25
Jan-12-24 Downgrade Barclays
Overweight → Equal Weight
$18
Jan-08-24 Downgrade RBC Capital Mkts
Sector Perform → Underperform
$16 → $14
Nov-01-23 Downgrade Goldman
Buy → Neutral
$30 → $17
Sep-05-23 Initiated Citigroup
Neutral
$19
Aug-02-23 Downgrade Wolfe Research
Outperform → Peer Perform
Aug-01-23 Downgrade Deutsche Bank
Buy → Hold
$20
Jul-24-23 Downgrade RBC Capital Mkts
Outperform → Sector Perform
$30 → $28
Jun-28-23 Initiated Needham
Buy
$35
May-04-23 Initiated DA Davidson
Buy
$30
Feb-07-23 Downgrade UBS
Buy → Neutral
$34 → $33
Jan-10-23 Downgrade Truist
Buy → Hold
$65 → $28
Jan-04-23 Downgrade BofA Securities
Buy → Neutral
$35 → $34
Show Previous Ratings
May-13-24 09:00AM
May-10-24 06:47PM
May-09-24 09:00AM
May-08-24 12:55PM
12:22PM
11:56AM
Loading…
11:56AM
11:27AM
10:32AM
10:26AM
10:22AM
09:34AM
08:57AM
08:14AM
(Thomson Reuters StreetEvents)
08:03AM
07:31AM
06:47AM
Loading…
06:47AM
06:45AM
06:45AM
May-07-24 10:30PM
05:48PM
05:38PM
05:15PM
04:27PM
04:15PM
(Associated Press Finance)
04:05PM
May-06-24 03:07AM
Apr-15-24 12:00PM
09:00AM
Apr-10-24 09:00AM
Apr-09-24 09:00AM
07:00AM
Loading…
07:00AM
Apr-02-24 04:30AM
Apr-01-24 07:22AM
Mar-13-24 12:04PM
Mar-05-24 05:28AM
Feb-26-24 05:45PM
Feb-20-24 09:00AM
Feb-15-24 05:00PM
Feb-13-24 08:03PM
04:24PM
01:14PM
01:14PM
01:13PM
12:44PM
10:08AM
08:55AM
(Thomson Reuters StreetEvents)
08:46AM
Feb-12-24 09:15PM
05:44PM
05:15PM
04:38PM
04:26PM
(Associated Press Finance)
04:13PM
04:05PM
Feb-11-24 02:00AM
Feb-09-24 12:10PM
Feb-06-24 09:00AM
Jan-29-24 07:14PM
02:44PM
10:57AM
Jan-26-24 06:15AM
Jan-16-24 09:00AM
02:39AM
Jan-15-24 01:30AM
Jan-08-24 10:06AM
Dec-21-23 05:00PM
12:09PM
Dec-13-23 08:27PM
Dec-12-23 12:17PM
Dec-06-23 05:00PM
Nov-30-23 09:00AM
Nov-28-23 02:39AM
Nov-14-23 09:00AM
Nov-02-23 08:00PM
Nov-01-23 02:50AM
Oct-31-23 05:07PM
11:42AM
09:37AM
Oct-30-23 11:00PM
05:55PM
05:40PM
04:33PM
(Associated Press Finance)
04:13PM
04:05PM
Oct-16-23 05:26PM
09:00AM
Oct-11-23 04:00AM
Sep-29-23 02:54AM
Sep-28-23 10:17AM
Sep-20-23 09:00AM
Sep-19-23 06:38AM
Sep-11-23 11:21AM
Sep-08-23 05:08PM
02:02PM
Sep-07-23 09:00AM
Sep-06-23 09:00AM
Sep-05-23 10:06AM
Sep-03-23 07:51AM
Aug-31-23 05:08PM
Aug-22-23 01:46AM
ZoomInfo Technologies, Inc. is a holding company, which engages in the provision of a cloud-based platform that offers information on organizations and professionals for sales and marketing teams. It offers sales leadership, sales development, marketing, and demand generation, sales and marketing operations, and recruiting. The company was founded by Henry L. Schuck and Kirk N. Brown in 2007 and is headquartered in Vancouver, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Dasdan Ali Chief Technology Officer Mar 04 '24 Sale 16.56 6,334 104,916 69,954 Mar 05 04:45 PM Dasdan Ali Chief Technology Officer Dec 04 '23 Sale 14.69 5,007 73,577 50,953 Dec 05 04:57 PM Dasdan Ali Chief Technology Officer Sep 14 '23 Sale 17.27 11,977 206,800 35,929 Sep 18 04:26 PM Cadambi Sriprasadh Chief Accounting Officer Sep 05 '23 Sale 18.16 9,218 167,399 0 Sep 07 04:37 PM Hyzer Peter Cameron Chief Financial Officer Jul 05 '23 Sale 25.46 10,000 254,600 1,185,565 Jul 07 04:15 PM Hays Joseph Christopher Pres, Chief Operating Officer Jun 20 '23 Sale 26.49 30,000 794,733 551,456 Jun 20 04:47 PM Schuck Henry Chief Executive Officer Jun 16 '23 Sale 26.52 2,000,000 53,046,114 10,288,001 Jun 20 04:25 PM Schuck Henry Chief Executive Officer Jun 16 '23 Sale 26.26 83,334 2,187,949 279,043 Jun 20 04:25 PM Cadambi Sriprasadh Chief Accounting Officer Jun 13 '23 Sale 28.25 1,207 34,098 9,218 Sep 07 04:37 PM Hyzer Peter Cameron Chief Financial Officer Jun 05 '23 Sale 26.46 10,000 264,606 1,172,653 Jun 07 05:07 PM Cadambi Sriprasadh Chief Accounting Officer May 25 '23 Sale 23.10 4,832 111,619 10,425 Sep 07 04:37 PM Hays Joseph Christopher Pres, Chief Operating Officer May 22 '23 Sale 25.03 30,000 750,972 581,171 May 24 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
